This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
TORONTO -- AuntMinnie.com spoke with cardiac PET imaging expert Krishna Patel, MD, from Mount Sinai in New York City, at the Society of Nuclear Medicine and Molecular Imaging annual meeting. She discussed what’s termed ischemia with non-obstructive coronary arteries (INOCA) and how new PET radiotracers may be a game changer in treating the condition.
The use of 90Y-FAPI-46 radioligand therapy resulted in controlled disease progression in nearly half of a 30-person cohort largely comprised of patients with advanced sarcomas, according to new research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting.
An emerging PET/CT radiotracer may be more predictive of progressive pulmonary fibrosis in interstitial lung patients than F-18 FDG PET/CT, according to research presented June 8 at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI). Fibroblast activation protein inhibitor (FAPI) PET/CT demonstrated heightened and extensive uptake in interstitial lung disease (ILD) compared to FDG in a cohort of 97 patients with ILD.
For patients with interstitial lung disease, FAPI PET/CT was more effective than 18F-FDG PET/CT at predicting progressive pulmonary fibrosis according to comparative study findings presented at the 2024 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
An emerging radioligand therapy could be particularly effective for controlling advanced sarcoma compared to other cancers, according to research presented June 8 in a Young Investigator Award session at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in Toronto. This yttrium-90 (Y-90)-labeled fibroblast activation protein inhibitor (FAPI)-46 research comes from Helena Lanzafame, MD, and colleagues from the department of nuclear medicine at University Hospital Essen in Germ
Cybil Nielsen has been elected as the 2024-2025 president-elect for the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Technologist Section. Cybil Nielsen of Gurnick Academy of Medical Arts in Concord, CA. Image courtesy of SNMMI. Nielsen, a nuclear medicine educator at Gurnick Academy of Medical Arts in Concord, CA, was among a new slate of officers introduced June 9 during the SNMMI’s annual meeting in Toronto.
In addition to new advances in PET/CT imaging to facilitate precision imaging, the company will also unveil a device at the SNMMI conference that allows in-house production of commercial PET tracers.
When employers make investments in the health of their employees, they reap a manifold benefit to those investments: their employees thrive, their business thrives, and the societies in which they operate thrive. There’s a positive opportunity that arises when employers address the inherent interconnectedness between work and health. The McKinsey Health Institute (MHI) has identified drivers of health that employers can influence and would be wise to support.
Ongoing Alzheimer's research is crucial for developing early detection methods, effective treatments, and comprehensive caregiver support. The post Understanding the Importance of Ongoing Alzheimer’s Research appeared first on Open MedScience.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content